Read More Pharma Industry News Allay Therapeutics raises $57.5m to advance ATX101 non-opioid pain therapy in knee surgery Allay Therapeutics raises $57.5M to advance ATX101 pain therapy in U.S. knee surgery trial, with FDA backing and growing Asia partnerships. byPallavi MadhirajuJune 7, 2025